|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.00 TWD | +0.40% |
|
+3.33% | -59.21% |
| Market Cap | 8.28B 258M 226M 208M 194M 367M 24.65B 372M 2.5B 971M 12.1B 971M 949M 41.95B | P/E 2024 |
524x | P/E 2025 | -255x |
|---|---|---|---|---|---|
| Enterprise Value | 5.99B 187M 164M 151M 140M 266M 17.83B 269M 1.8B 702M 8.75B 702M 686M 30.34B | EV / Sales 2024 |
1,207x | EV / Sales 2025 | 6,544x |
| Free-Float |
56.63% | Yield 2024 |
0.18% | Yield 2025 | 0.03% |
| 1 day | +0.40% | ||
| 1 week | +3.33% | ||
| Current month | +6.44% | ||
| 1 month | +3.77% | ||
| 3 months | -25.75% | ||
| 6 months | -55.71% | ||
| Current year | -59.21% |
| 1 week | 116 |  | 127 |
| 1 month | 111 | | 127 |
| Current year | 111 | | 313 |
| 1 year | 111 | | 317 |
| 3 years | 108.5 | | 465 |
| 5 years | 42.8 | | 465 |
| 10 years | 42.8 | | 465 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yung Shun Wen
CEO | Chief Executive Officer | - | 2016-09-22 |
Vivian Kang
DFI | Director of Finance/CFO | - | 2019-10-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Lin
CHM | Chairman | - | 2016-09-22 |
Yung Shun Wen
BRD | Director/Board Member | - | 2016-09-22 |
Cheng Yu Fang
BRD | Director/Board Member | - | 2018-08-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | +3.33% | -10.79% | -24.16% | 258M | |
| -2.15% | -2.01% | +56.65% | +13.45% | 313B | |
| -0.58% | -2.96% | +30.32% | -2.73% | 70.89B | |
| +1.67% | +4.66% | +49.59% | +120.65% | 9.58B | |
| -0.77% | +4.93% | +8.41% | +3.43% | 8.82B | |
| -5.79% | +6.58% | +18.45% | +30.79% | 4.25B | |
| -2.55% | -7.79% | -8.10% | +8.11% | 4.29B | |
| -1.14% | -5.69% | -34.65% | +26.00% | 3.39B | |
| -1.69% | +0.94% | +47.72% | +59.97% | 2.74B | |
| +1.66% | +1.88% | +17.18% | -19.63% | 2.22B | |
| Average | -1.09% | +2.91% | +17.48% | +21.59% | 41.96B | |
| Weighted average by Cap. | -1.77% | +2.42% | +48.93% | +13.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.82M 181K 159K 146K 136K 258K 17.31M 262K 1.75M 682K 8.5M 682K 667K 29.46M | 2.75M 85.89K 75.22K 69.29K 64.31K 122K 8.19M 124K 829K 323K 4.02M 323K 315K 13.94M |
| Net income | 18.17M 567K 496K 457K 424K 806K 54.07M 817K 5.47M 2.13M 26.54M 2.13M 2.08M 92.03M | -79.68M -2.49M -2.18M -2.01M -1.86M -3.53M -237M -3.58M -24.01M -9.34M -116M -9.34M -9.13M -404M |
| Net Debt | -2.43B -75.83M -66.41M -61.17M -56.78M -108M -7.23B -109M -732M -285M -3.55B -285M -279M -12.31B | -2.29B -71.53M -62.65M -57.7M -53.56M -102M -6.82B -103M -691M -269M -3.35B -269M -263M -11.61B |
Employees
32
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | NT$124.00 | +0.40% | 70,494 |
| 26-07-03 | NT$123.50 | +4.66% | 117,917 |
| 26-07-02 | NT$118.00 | 0.00% | 43,339 |
| 26-07-01 | NT$118.00 | +1.29% | 59,248 |
| 26-06-30 | NT$116.50 | -2.92% | 60,144 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 6785 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
